Ordering information regarding a Cyclic Citrullinated Peptide (CCP) Antibody, IgG test for Clinical Diagnostic Laboratories. Cyclic Citrullinated Peptide (CCP) Antibody, IgG Ordering Recommendation Highly specific serologic test that aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Urine or plasma. Contaminated, hemolyzed, grossly icteric, heat-inactivated, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated. Note CPT Code 86200 Components Component Chart Name Cyclic Citrullinated Peptide Ab, IgG Component Test Code 0055256 LOINC 33935-8 Aliases ACPA Antibody Anti Citrullinated Antibody Anti Citrulline Anti-CCP Anti-CCP Antibody Anti-Citrullinated Ab Anti-Citrullinated Antibody Anti-Citrullinated Protein/Peptide Antibody (ACPA) Anti-Citrulline Antibody Anti-Cyclic Citrullinated Peptide AntiCCP Antibody Anticitrullinated Antibody Anticitrullinated Protein/Peptide Antibody (ACPA) Anticitrulline Antibody Anticyclic Citrullinated Peptide (CCP) Antibody CCP CCP3 Antibody Citrullinated Ab Citrullinated Antibody Citrullinated Protein/Peptide Antibody (ACPA) Citrulline An tibody Soft-CCP

The product page for the men's health panel at Clinical Diagnostic Laboratories. Men's Health Panel Take charge of your health with this comprehensive blood test panel designed specifically for men. Whether you're focused on energy levels, heart health, hormone balance, or just getting a clearer picture of your overall wellness, this panel covers the essentials. Here’s what it checks — and why it matters: Complete Blood Count (CBC) – Measures your white and red blood cells to detect signs of infection, fatigue, or anemia. Comprehensive Metabolic Panel (CMP) – Evaluates your liver and kidney function, electrolytes, and blood sugar levels. Lipid Panel – Checks your cholesterol, including “good” (HDL) and “bad” (LDL) cholesterol, to assess your heart disease risk. Testosterone, Total – Measures your testosterone levels, which impact energy, muscle mass, mood, and sexual health. PSA, Total – Screens for signs of prostate issues, which is especially important as men age. Recommended for men over 50. Hemoglobin A1C – Provides a long-term view of your blood sugar levels to check for prediabetes or diabetes. Vitamin B12 – Plays a crucial role in the formation of red blood cells, the synthesis of DNA, and the maintenance of nerve cells. TSH (Thyroid-Stimulating Hormone) – Helps detect thyroid issues that can affect metabolism, weight, and energy. With just one visit to our lab, you’ll gain valuable insight into your health — without needing a doctor’s referral or insurance. $241.00 Taxes will be calculated at checkout Buy Now

The Terms and Conditions of Clinical Diagnostic Laboratories located in Sterling and Ashburn is located on this page. Terms & Conditions 1. Acceptance of Terms Welcome to Clinical Diagnostic Laboratories ("we," "us," or "our"). By accessing or using our services, including our website and any related applications (collectively referred to as the "Services"), you agree to comply with and be bound by these Terms and Conditions. If you do not agree to these terms, please refrain from using our Services. 2. Services Offered Clinical Diagnostic Laboratories provides comprehensive diagnostic testing services including, but not limited to, blood panels, allergy tests, COVID tests, and Influenza tests. These services are available at our two separate locations: 2 Pidgeon Hill Dr., Suite 150, Sterling, VA 20165, and 44355 Premier Plaza, Suite 240, Ashburn, VA 20147. 3. Test Accuracy and Interpretation While we strive to provide accurate and reliable test results, it is important to note that medical tests may have limitations and potential variations. Test results should be interpreted by qualified medical professionals, and we strongly recommend consulting a healthcare provider for accurate diagnosis and treatment recommendations based on the test results. 4. Privacy and Data Security We are committed to protecting your privacy and the security of your personal and medical information. Our Privacy Policy outlines the types of data we collect, how it is used, and the measures we take to safeguard your information. By using our Services, you agree to our Privacy Policy. 5. Payment and Billing We offer various payment options for our services. Payment details, including pricing and payment methods, are available on our website and will be provided during the checkout process. Any additional fees, taxes, or charges associated with the services will be clearly communicated. 6. Appointments and Cancellations Appointments for tests are subject to availability and can be scheduled through our website or by contacting our customer service. If you need to cancel or reschedule an appointment, please provide notice in advance according to our cancellation policy, which will be communicated during the appointment scheduling process. 7. Test Preparation Instructions Specific tests may require certain preparations, such as fasting or medication restrictions. Customers are responsible for following these instructions to ensure accurate test results. 8. Turnaround Time for Results We strive to provide test results within a specific timeframe. However, factors such as test complexity and demand may impact the turnaround time. 9. Refund and Return Policy If services are paid for but not utilized, our refund and return policy applies. Details can be found on our website or obtained by contacting customer service. 10. Communication Channels For inquiries, support, or appointment scheduling, contact us via email, phone, or our designated customer portal. 11. Insurance and Coverage Information about insurance coverage, billing procedures, and reimbursement for services covered by insurance can be found on our website or by contacting us directly. 12. Laboratory Accreditation and Certifications Clinical Diagnostic Laboratories maintains specific accreditations and certifications that demonstrate our commitment to q uality and accuracy. 13. Health and Safety Measures To ensure a safe testing environment, we adhere to rigorous health and safety protocols for the protection of both patients and staff. 14. Dispute Resolution Any disputes will be resolved through mediation or arbitration, with the applicable jurisdiction specified. 15. Legal Disclaimers Our services are for diagnostic purposes only. Customers should consult healthcare professionals for medical advice and treatment. 16. User Accounts (if applicable) If you create a user account on our platform, terms related to account creation, management, and security apply. 17. Governing Law These Terms and Conditions are governed by and construed in accordance with the laws of the state of Virginia, without regard to its conflict of laws principles. 18. Conta ct Us If you have any questions, concerns, or feedback regarding these Terms and Conditions or our Services, please contact us at: Clinical Diagnostic Laboratories 2 Pidgeon Hill Dr., Suite 150, Sterling, VA 20165 44355 Premier Plaza, Suite 240, Ashburn, VA 20147 Email: info@clinicaldiagnosticlab.com Phone: (703) 430-1111 Fax: (703) 722-3890

Ordering information regarding Beta-2 Glycoprotein 1 Antibodies, IgG and IgM test for Clinical Diagnostic Laboratories. Beta-2 Glycoprotein 1 Antibodies, IgG and IgM Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Cardiolipin Antibodies, IgG and IgM (0099344 ). May also be useful in estimating risk of thrombosis and/or pregnancy-related morbidity in patients with systemic lupus erythematosus (SLE). Mnemonic B2GPI PAN Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval Reference Interval Components <=20 SGU B2Glycoprotein 1, IgG Antibody <=20 SMU B2Glycoprotein 1, IgM Antibody Interpretive Data The persistent presence of IgG and/or IgM beta 2 glycoprotein I (B2GPI) antibodies is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM B2GPI antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). B2GPI results greater than 20 SGU (IgG) and/or SMU (IgM) are considered positive based on the cutoff values established for this test. International reference materials and consensus units for anti-B2GPI antibodies have not been established (Clin Chim Acta. 2012;413(1-2):358-60; Arthritis Rheum. 2012;64(1):1-10.); results can be variable between different commercial immunoassays and cannot be compared. Strong clinical correlation is recommended for a diagnosis of APS. Low positive IgG and IgM B2GPI antibody levels should be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86146 x2 Components Component Chart Name B2Glycoprotein 1, IgG Antibody Component Test Code 0050322 LOINC 44448-9 0050323 B2Glycoprotein 1, IgM Antibody 44449-7 Aliases Anti-B2-Glycoprotein 1 Anti-B2-Glycoprotein I Anti-B2-GP 1 Anti-B2-GP1 Anti-B2-GPI Anti-beta-2 glycoprotein 1 Anti-beta-2 glycoprotein I Apolipoprotein H Apolipoprotein H, APOH B2 Glycoprotein 1 antibodies B2GP Antibodies B2GP1 B2GPI IgG, IgM BECKY Beta 2 GP1 Ab IgG Beta 2 GP1 Ab IgM Beta 2GP1 Ab Beta 2Glycoprotein 1 Please Also View: Beta-2 GlycoProtein 1 Antibody, igA

Ordering information regarding a Cardiolipin Antibody, IgM test for Clinical Diagnostic Laboratories. Beta-2 Glycoprotein 1 Antibody, IgA Ordering Recommendation Preferred second-line test when seronegative antiphospholipid syndrome (APS) is strongly suspected. Order incrementally or concurrently with other noncriteria antiphospholipid antibody tests. May also be useful in estimating risk of thrombosis and/or pregnancy-related morbidity in patients with SLE. Mnemonic B2GPI A Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval <=20 SAU Interpretive Data Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86146 Components Component Chart Name B2Glycoprotein 1, IgA Antibody Component Test Code 0050324 LOINC 21108-6 Aliases Anti-B2-Glycoprotein 1 Anti-B2-Glycoprotein I Anti-B2-GP 1 Anti-B2-GP I Anti-B2-GP1 Anti-B2-GPI Anti-Beta-2-Glycoprotein I APOH Apolipoprotein H B2 IgA B2-glycoprotein 1 IgA B2GP1 IgA Beta 2GP1 Ab Please Also View: Beta-2 GlycoProtein 1 Antibody, igA

Ordering information regarding a Tryptase test for Clinical Diagnostic Laboratories. Tryptase Ordering Recommendation Measure total tryptase to confirm mast cell activation in diseases such as mastocytosis, anaphylaxis, urticaria, and asthma. Not generally used acutely except where the diagnosis is unclear. Useful in the prognosis of systemic mastocytosis. Mnemonic EGGWHOLE Methodology Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay Performed Mon-Sat Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Allow serum to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Frozen. Unacceptable Conditions: Hemolyzed, icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 72 hours; Frozen: 1 month Reference Interval Less than 11.0 µg/L Interpretive Data Compliance Category: FDA Note This test measures total tryptase and does not distinguish between the alpha and beta protein types. Samples should preferably be collected between 15 minutes and three hours after the event suspected to have caused mast cell activation. CPT Code 83520 Components Component Chart Name Tryptase Component Test Code 0099173 LOINC 21582-2 Aliases Total Tryptase Tryptase, Autopsy (Tryptase)

Clinical Diagnostic Laboratories is a registered, female‑owned, minority company open to partnerships with government agencies. We offer reliable diagnostic testing services and welcome opportunities to collaborate — contact us to learn more. Services for Government Agencies Clinical Diagnostics Laboratories does not currently work with any government agencies but we are registered in the same database and are a female-owned and operated, minority company. Clinical Diagnostics Laboratories is always available and open for opportunities. If you're interested in learning more about our services or are interested in working with us, please contact us for more information. CONTACT US

Ordering information regarding a ​Rheumatoid Factor (RF) for Clinical Diagnostic Laboratories. Rheumatoid Factor (RF) Ordering Recommendation Aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Consider ordering this test in conjunction with Cyclic Citrullinated Peptide (CCP) Antibody, IgG (0055256 ) to increase specificity and sensitivity. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Quantitative Immunoturbidimetry Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Fasting specimen preferred. Collect: Serum separator tube or plasma separator tube. Also acceptable: Green (lithium heparin), lavender or pink. Specimen Preparation: Allow the specimen to clot completely at room temperature. Transfer 0.5 mL serum or plasma to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or grossly lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 8 days; Frozen: 3 months (should not be thawed more than once) Reference Interval 0-14 IU/mL Interpretive Data Note CPT Code 86431 Components Component Chart Name Rheumatoid Factor Component Test Code 0050465 LOINC 11572-5 Aliases RA RF Rheumatoid Arthritis Factor

Ordering information regarding a Anti-Mitochondrial Antibody (AMA) test for Clinical Diagnostic Laboratories. Mitochondrial M2 Antibody, IgG (ELISA) Ordering Recommendation May be useful in confirming a diagnosis of primary biliary cholangitis. Mnemonic AMA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 20.0 Units or less Negative 20.1-24.9 Units 25.0 Units or greater Equivocal Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Mitochondrial (M2) Antibody, IgG Component Test Code 0050065 LOINC 14251-3 Aliases AMA ANTI-MITOCHONDIRAL ANTIBODY ANTIBODIES TO MICROTUBULE ASSOCIATED PROTEIN 2 ANTIMITOCHONDRIAL ANTIBODIES IMMUNOLOGY PROFILE (AMA) MITOCHONDRIAL ANTIBODIES, SERUM

The product page for the Immunochemical Test at Clinical Diagnostic Laboratories. InSure ONE - One Day Fecal Immunochemical Test *The Fecal Immunochemical kit, as well as a prepaid return envelope, will be shipped to you* A simple, non-invasive test that helps you screen for early signs of colon cancer — from the comfort of home. No doctor’s order, no insurance, no hassle. Colon cancer often develops silently, with no symptoms in the early stages. The InSure® ONE FIT test makes it easy to check for hidden blood in your stool, a key early indicator of colorectal disease, so you can take control of your health before problems become serious. This test is quick, clean, and designed for anyone who wants reliable screening without the stress of appointments, referrals, or long waits. A highly sensitive test that detects tiny, invisible traces of blood in your stool — something you can’t see on your own. Uses advanced antibody technology to identify blood from the lower colon. Does not require diet changes, fasting, or multiple stool samples. Helps identify early warning signs of colon cancer, polyps, or gastrointestinal bleeding. Even if you feel completely fine, FIT testing is one of the easiest and most effective ways to stay ahead of colorectal health issues. Why people choose the InSure® ONE FIT test: Simple at-home collection — no mess and no bathroom handling. Only one sample required — done in minutes. No dietary restrictions before completing the test. Great for routine screening or peace of mind between doctor visits. Fast, accurate processing by our CLIA-certified lab. Ideal for adults who prefer private, accessible screening without insurance barriers. Who is this test for? Perfect for individuals who want: A quick annual colorectal cancer screening A private, self-pay option without waiting for a doctor’s appointment Monitoring between colonoscopies (as advised by a physician) A simple way to stay proactive about their health $35.50 Taxes will be calculated at checkout Buy Now